84487-12-7 Usage
Uses
Used in Pharmaceutical Industry:
4-Pyridinamine, 2-methyl-5-nitrois used as a key intermediate in the synthesis of various drugs for the treatment of different medical conditions. It plays a crucial role in the production of Tadalafil, a medication used to treat erectile dysfunction, and Roflumilast, a medication used to treat chronic obstructive pulmonary disease (COPD).
Used in Agrochemical Industry:
4-Pyridinamine, 2-methyl-5-nitrois also used as a building block in the synthesis of agrochemicals, contributing to the development of effective pesticides and other agricultural products.
Used in Organic Synthesis:
4-Pyridinamine, 2-methyl-5-nitrohas applications in the field of organic synthesis, where it serves as a versatile starting material for the preparation of various organic compounds with potential applications in different industries.
Used in Medicinal Chemistry:
4-Pyridinamine, 2-methyl-5-nitrois utilized in medicinal chemistry for the design and development of new pharmaceutical agents, as its unique structure allows for the creation of diverse chemical entities with potential therapeutic properties.
Check Digit Verification of cas no
The CAS Registry Mumber 84487-12-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,4,4,8 and 7 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 84487-12:
(7*8)+(6*4)+(5*4)+(4*8)+(3*7)+(2*1)+(1*2)=157
157 % 10 = 7
So 84487-12-7 is a valid CAS Registry Number.
84487-12-7Relevant academic research and scientific papers
The synthesis of 6-deazaformycin A
Tite, Tony,Lougiakis, Nikolaos,Marakos, Panagiotis,Pouli, Nicole
scheme or table, p. 2927 - 2930 (2010/02/28)
The synthesis of the new C-nucleoside 6-deazaformycin A was achieved through the condensation of a suitably substituted lithiated 2-picoline with 2,3,5-tri-O-benzyl-d-ribonolactone, borohydride reduction of the resulting hemiacetals, followed by intramolecular Mitsunobu cyclization of the carbinols, manipulation of the protecting groups, and subsequent ring closure to result in the formation of 7-amino-3-(β-d-ribofuranosyl)pyrazolo[4,3-b]pyridine. Georg Thieme Verlag Stuttgart.
